Zentiva Group, a.s. Sustainability Profile
Zentiva Group, a.s., headquartered in the Czech Republic, is a prominent player in the pharmaceutical industry, specialising in generic and over-the-counter medicines. Founded in 1998, the company has established a strong presence across Central and Eastern Europe, focusing on delivering high-quality, affordable healthcare solutions. Zentiva's core product offerings include a diverse range of generic pharmaceuticals, which are distinguished by their commitment to quality and accessibility. The company has achieved significant milestones, including expanding its portfolio and enhancing its manufacturing capabilities, positioning itself as a trusted provider in the market. With a dedication to innovation and patient-centric solutions, Zentiva continues to strengthen its market position, contributing to improved health outcomes across the regions it serves.
DitchCarbon Score
How does Zentiva Group, a.s.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Real Estate Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Zentiva Group, a.s.'s score of 23 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Zentiva Group, a.s.'s reported carbon emissions
In 2024, Zentiva Group, a.s. reported total carbon emissions of approximately 54,749,000 kg CO2e. This includes Scope 1 emissions of about 3,931,000 kg CO2e, Scope 2 emissions of approximately 3,264,000 kg CO2e, and significant Scope 3 emissions totalling around 50,818,000 kg CO2e. The Scope 3 emissions breakdown reveals major contributions from purchased goods and services (approximately 43,554,000 kg CO2e) and end-of-life treatment of sold products (around 924,000 kg CO2e). Zentiva has set ambitious climate commitments, aiming for carbon neutrality in Scope 1 and Scope 2 emissions by 2030. This commitment is contingent on advancements in process technology and operational practices. Furthermore, the company has established long-term targets through the Science Based Targets initiative (SBTi), committing to a 63% reduction in absolute Scope 1 and 2 emissions by 2034 from a 2021 baseline, and a 90% reduction by 2050. For Scope 3 emissions, a similar 63% reduction is targeted by 2034 from a 2024 baseline, with a 90% reduction goal by 2050. Zentiva's climate strategy is aligned with the 1.5°C pathway, reflecting its commitment to sustainable practices within the pharmaceuticals, biotechnology, and life sciences sector. The emissions data and targets are cascaded from the parent organization, Zentiva Group, a.s., ensuring a cohesive approach to climate action across its operations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2024 | |
|---|---|---|
| Scope 1 | 305,480,000 | 0,000,000 |
| Scope 2 | 79,081,000 | 0,000,000 |
| Scope 3 | - | 00,000,000 |
How Carbon Intensive is Zentiva Group, a.s.'s Industry?
How Carbon Intensive is Zentiva Group, a.s.'s Location?
Zentiva Group, a.s.'s Scope 3 Categories Breakdown
The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 86% of Scope 3 emissions.
Top Scope 3 Categories
Zentiva Group, a.s.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Zentiva Group, a.s. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
